Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
RENALIT-COMBI COLIC
- Development stage
- Unknown
- Lead developer
- Bio-STILOGIT Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
RENALIT-COMBI COLIC is a dietary supplement developed by Bio-STILOGIT Pharmaceuticals, primarily marketed in Italy for the management of nephrolithiasis (kidney stones) and the relief of renal colic. The formulation typically combines potassium citrate and magnesium citrate with the botanical extract *Phyllanthus niruri*. The citrate components serve as urinary alkalinizers and inhibitors of calcium stone formation by increasing urinary pH and sequestering calcium ions into soluble complexes. *Phyllanthus niruri*, often referred to as stone breaker, is included for its potential litholytic effects and its ability to relax urinary tract smooth muscle, which facilitates the passage of stones and reduces the pain associated with colic episodes. The product is sold as a retail consumer health product and is not classified as a prescription pharmaceutical.
- Brand names
- RENALIT-COMBI COLIC
- Other names
- Renalit-Combi Colic
02
Targets
ADRA1A (α1A)
Beyond the preview
Go deeper on RENALIT-COMBI COLIC.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RENALIT-COMBI COLIC.